Central Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.38M Sell
105,155
-1,085
-1% -$63.3K 0.13% 118
2025
Q4
$5.73M Sell
106,240
-6,408
-6% -$308K 0.11% 129
2025
Q3
$5.08M Sell
112,648
-9,285
-8% -$434K 0.11% 151
2025
Q2
$5.64M Sell
121,933
-15,782
-11% -$775K 0.13% 127
2025
Q1
$8.4M Buy
137,715
+350
+0.3% +$20.4K 0.21% 84
2024
Q4
$7.77M Sell
137,365
-8,324
-6% -$465K 0.19% 90
2024
Q3
$7.54M Sell
145,689
-3,015
-2% -$141K 0.18% 100
2024
Q2
$6.18M Sell
148,704
-18,559
-11% -$830K 0.15% 111
2024
Q1
$9.07M Sell
167,263
-11,495
-6% -$586K 0.23% 82
2023
Q4
$9.17M Sell
178,758
-24,390
-12% -$1.28M 0.24% 82
2023
Q3
$11.8M Sell
203,148
-13,348
-6% -$818K 0.34% 61
2023
Q2
$13.8M Sell
216,496
-10,132
-4% -$679K 0.39% 54
2023
Q1
$15.7M Buy
226,628
+2,010
+0.9% +$142K 0.46% 46
2022
Q4
$16.2M Sell
224,618
-8,679
-4% -$654K 0.5% 46
2022
Q3
$16.6M Sell
233,297
-1,186
-0.5% -$86K 0.57% 42
2022
Q2
$18.1M Sell
234,483
-9,371
-4% -$714K 0.6% 39
2022
Q1
$17.8M Sell
243,854
-12,231
-5% -$821K 0.51% 43
2021
Q4
$16M Sell
256,085
-23,577
-8% -$1.38M 0.45% 48
2021
Q3
$16.5M Buy
279,662
+83
+0% +$5.47K 0.59% 39
2021
Q2
$18.7M Sell
279,579
-4,866
-2% -$317K 0.68% 33
2021
Q1
$18M Buy
284,445
+5,791
+2% +$360K 0.7% 31
2020
Q4
$17.3M Sell
278,654
-2,843
-1% -$175K 0.71% 33
2020
Q3
$17M Buy
281,497
+14,308
+5% +$861K 0.77% 33
2020
Q2
$15.7M Buy
267,189
+28,292
+12% +$1.69M 0.79% 32
2020
Q1
$13.3M Buy
238,897
+12,526
+6% +$766K 0.82% 29
2019
Q4
$14.5M Buy
226,371
+78,958
+54% +$4.52M 0.74% 35
2019
Q3
$7.47M Sell
147,413
-1,594
-1% -$74.9K 0.42% 57
2019
Q2
$6.63M Sell
149,007
-485
-0.3% -$22.6K 0.38% 62
2019
Q1
$7.13M Sell
149,492
-2,475
-2% -$123K 0.43% 56
2018
Q4
$7.9M Sell
151,967
-7,306
-5% -$393K 0.53% 46
2018
Q3
$9.89M Sell
159,273
-2,370
-1% -$141K 0.57% 40
2018
Q2
$8.95M Sell
161,643
-8,336
-5% -$450K 0.57% 38
2018
Q1
$10.8M Sell
169,979
-12,396
-7% -$797K 0.68% 34
2017
Q4
$11.2M Sell
182,375
-1,812
-1% -$113K 0.68% 33
2017
Q3
$11.7M Buy
184,187
+20,092
+12% +$1.17M 0.76% 33
2017
Q2
$9.14M Sell
164,095
-18,149
-10% -$988K 0.6% 39
2017
Q1
$9.91M Sell
182,244
-11,001
-6% -$603K 0.66% 38
2016
Q4
$11.3M Sell
193,245
-146
-0.1% -$7.98K 0.78% 34
2016
Q3
$10.4M Buy
193,391
+10,289
+6% +$661K 0.76% 28
2016
Q2
$13.5M Buy
183,102
+2,368
+1% +$167K 1.01% 22
2016
Q1
$11.5M Buy
180,734
+949
+0.5% +$59.8K 0.91% 24
2015
Q4
$12.4M Sell
179,785
-981
-0.5% -$64.8K 1.02% 21
2015
Q3
$10.7M Sell
180,766
-859
-0.5% -$54.5K 0.93% 22
2015
Q2
$12.1M Buy
181,625
+207
+0.1% +$13.6K 0.95% 23
2015
Q1
$11.7M Buy
181,418
+8,899
+5% +$557K 0.94% 24
2014
Q4
$10.2M Sell
172,519
-3,480
-2% -$196K 0.83% 29
2014
Q3
$9.01M Sell
175,999
-11,862
-6% -$593K 0.72% 31
2014
Q2
$9.11M Sell
187,861
-8,801
-4% -$434K 0.72% 30
2014
Q1
$10.2M Sell
196,662
-1,227
-0.6% -$65.3K 0.84% 27
2013
Q4
$10.5M Sell
197,889
-1,278
-0.6% -$65.1K 0.88% 27
2013
Q3
$9.22M Sell
199,167
-266
-0.1% -$11.7K 0.83% 27
2013
Q2
$8.91M Buy
+199,433
New +$8.66M 0.85% 28

Other funds holding BMY

Central Trust Company's BMY Position: Q1 2026 in Review

Central Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 1% in Q1 2026, selling an estimated $63.3K and leaving 105,155 shares worth $6.38M. The position accounts for 0.13% of the portfolio, ranked #118.

Central Trust Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.7M in Q2 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Central Trust Company held 105,155 shares of Bristol-Myers Squibb worth $6.38M as of Q1 2026.
  • Central Trust Company sold 1,085 Bristol-Myers Squibb shares in Q1 2026, an estimated $63.3K.
  • Bristol-Myers Squibb made up 0.13% of Central Trust Company's portfolio in Q1 2026, its #118 holding.
  • Central Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's Bristol-Myers Squibb position peaked at $18.7M in Q2 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.